Imaging of cartilage and bone: Promises and pitfalls in clinical trials of osteoarthritis

Osteoarthritis and Cartilage

Volumn 22, Issue 10, 2014, Pages 1516-1532

  Eckstein, F ^a,b   Guermazi, A ^c,d   Gold, G ^e   Duryea, J ^f   Hellio Le Graverand, M P ^g   Wirth, W ^a,b   Miller, C G ^h  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b Chondrometrics GmbH   (Germany)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Boston Imaging Core Lab BICL   (United States)

^e STANFORD UNIVERSITY   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g PFIZER INC   (United States)

^h BioClinica Inc   (United States)

Author keywords

Bone; Cartilage; Clinical trial; Imaging; Recommendations

Indexed keywords

BIOLOGICAL MARKER;

BONE RADIOGRAPHY; CARTILAGE; CARTILAGE IMAGING; DIAGNOSTIC IMAGING; HUMAN; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; KNEE PAIN; MENISCECTOMY; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); MUSCULOSKELETAL SYSTEM EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPHYTE; PHASE 3 CLINICAL TRIAL (TOPIC); QUALITY CONTROL; QUALITY OF LIFE; REVIEW; WEIGHT BEARING; ARTICULAR CARTILAGE; CLINICAL TRIAL (TOPIC); FEMUR; KNEE; OSTEOARTHRITIS; OSTEOARTHRITIS, KNEE; PATHOLOGY; RADIOGRAPHY; TIBIA; TREATMENT OUTCOME;

CARTILAGE, ARTICULAR; CLINICAL TRIALS AS TOPIC; FEMUR; HUMANS; KNEE JOINT; MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OSTEOARTHRITIS, KNEE; TIBIA; TREATMENT OUTCOME;

EID: 84908219631     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.06.023     Document Type: Review

References (150)

1. Miller C.G. The metrics and new imaging marker qualification in medical imaging modalities 2014, Chapter 2, Springer, Medical Imaging in Clinical Trials, ISBN 978-1-84882-710-3. C.G. Miller, J. Krasnow, L.H. Schwatz (Eds.).
2. Dardzinski B.J., Schneider E. Radiofrequency (RF) coil impacts the value and reproducibility of cartilage spin-spin (T2) relaxation time measurements. Osteoarthr Cartil 2013, 21:710-720.
3. Eckstein F., Kunz M., Hudelmaier M., Jackson R., Yu J., Eaton C.B., et al. Impact of coil design on the contrast-to-noise ratio, precision, and consistency of quantitative cartilage morphometry at 3 Tesla: a pilot study for the osteoarthritis initiative. Magn Reson Med 2007, 57:448-454.
4. Schneider E., NessAiver M. The Osteoarthritis Initiative (OAI) magnetic resonance imaging quality assurance update. Osteoarthr Cartil 2013, 21:110-116.
5. Guermazi A., Hunter D.J., Li L., Benichou O., Eckstein F., Kwoh C.K., et al. Different thresholds for detecting osteophytes and joint space narrowing exist between the site investigators and the centralized reader in a multicenter knee osteoarthritis study-data from the Osteoarthritis Initiative. Skeletal Radiol 2012, 41:179-186.
6. Eckstein F., Burstein D., Link T.M. Quantitative MRI of cartilage and bone: degenerative changes in osteoarthritis. NMR Biomed 2006, 19:822-854.
7. Eckstein F., Mc Culloch C.E., Lynch J.A., Nevitt M., Kwoh C.K., Maschek S., et al. How do short-term rates of femorotibial cartilage change compare to long-term changes? Four year follow-up data from the Osteoarthritis Initiative. Osteoarthr Cartil 2012, 20:1250-1257.
8. Merle-Vincent F., Vignon E., Brandt K., Piperno M., Coury-Lucas F., Conrozier T., et al. Superiority of the Lyon Schuss view over the standing anteroposterior view for detecting joint space narrowing, especially in the lateral tibiofemoral compartment, in early knee osteoarthritis. Ann Rheum Dis 2007, 66:747-753.
9. Hellio Le Graverand M.P., Mazzuca S., Duryea J., Brett A. Radiographic grading and measurement of joint space width in osteoarthritis. Rheum Dis Clin North Am 2009, 35:485-502.
10. Marsh M., Souza R.B., Wyman B.T., Hellio Le Graverand M.P., Subburaj K., Link T.M., et al. Differences between X-ray and MRI-determined knee cartilage thickness in weight-bearing and non-weight-bearing conditions. Osteoarthr Cartil 2013, 21:1876-1885.
11. Messieh S.S., Fowler P.J., Munro T. Anteroposterior radiographs of the osteoarthritic knee. JBone Jt Surg Br 1990, 72:639-640.
12. Buckland-Wright J.C., Macfarlane D.G., Williams S.A., Ward R.J. Accuracy and precision of joint space width measurements in standard and macroradiographs of osteoarthritic knees. Ann Rheum Dis 1995, 54:872-880.
13. Peterfy C., Li J., Zaim S., Duryea J., Lynch J., Miaux Y., et al. Comparison of fixed-flexion positioning with fluoroscopic semi-flexed positioning for quantifying radiographic joint-space width in the knee: test-retest reproducibility. Skelet Radiol 2003, 32:128-132.
14. Vignon E., Piperno M., Le Graverand M.P., Mazzuca S.A., Brandt K.D., Mathieu P., et al. Measurement of radiographic joint space width in the tibiofemoral compartment of the osteoarthritic knee: comparison of standing anteroposterior and Lyon Schuss views. Arthritis Rheum 2003, 48:378-384.
15. Buckland-Wright J.C., Wolfe F., Ward R.J., Flowers N., Hayne C. Substantial superiority of semiflexed (MTP) views in knee osteoarthritis: a comparative radiographic study, without fluoroscopy, of standing extended, semiflexed (MTP), and schuss views. JRheumatol 1999, 26:2664-2674.
16. Le Graverand M.P., Vignon E.P., Brandt K.D., Mazzuca S.A., Piperno M., Buck R., et al. Head-to-head comparison of the Lyon Schuss and fixed flexion radiographic techniques. Long-term reproducibility in normal knees and sensitivity to change in osteoarthritic knees. Ann Rheum Dis 2008, 67:1562-1566.
17. Hellio Le Graverand M.P., Clemmer R.S., Brunell R.M., Hayes C.W., Miller C.G., Vignon E. Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography. Semin Arthritis Rheum 2013, 43:1-8.
18. Vignon E., Brandt K.D., Mercier C., Hochberg M., Hunter D., Mazzuca S., et al. Alignment of the medial tibial plateau affects the rate of joint space narrowing in the osteoarthritic knee. Osteoarthr Cartil 2010, 18:1436-1440.
19. Mercier C., Piperno M., Vignon E., Brandt K., Hochberg M., Hellio Le Graverand M.P. In normal knees, joint space width (JSW) is correlated with the intermargin distance (IMD), a measure of medial tibial plateau alignment. Variations in IMD explain variability in JSW in serial radiographs. Jt Bone Spine 2013, 80:183-187.
20. Hellio Le Graverand M.P., Clemmer R.S., Redifer P., Brunell R.M., Hayes C.W., Brandt K.D., et al. A2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann Rheum Dis 2013, 72:187-195.
21. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16:494-502.
22. Reichmann W.M., Maillefert J.F., Hunter D.J., Katz J.N., Conaghan P.G., Losina E. Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review. Osteoarthr Cartil 2011, 19:550-556.
23. Eckstein F., Wirth W., Hunter D.J., Guermazi A., Kwoh C.K., Nelson D.R., et al. Magnitude and regional distribution of cartilage loss associated with grades of joint space narrowing in radiographic osteoarthritis-data from the Osteoarthritis Initiative (OAI). Osteoarthr Cartil 2010, 18:760-768.
24. Bloecker K., Wirth W., Hunter D.J., Duryea J., Guermazi A., Kwoh C.K., et al. Contribution of regional 3D meniscus and cartilage morphometry by MRI to joint space width in fixed flexion knee radiography-a between-knee comparison in subjects with unilateral joint space narrowing. Eur J Radiol 2013, 82:e832-e839.
25. Schiphof D., Boers M., Bierma-Zeinstra S.M. Differences in descriptions of Kellgren and Lawrence grades of knee osteoarthritis. Ann Rheum Dis 2008, 67:1034-1036.
26. Felson D.T., Niu J., Guermazi A., Sack B., Aliabadi P. Defining radiographic incidence and progression of knee osteoarthritis: suggested modifications of the Kellgren and Lawrence scale. Ann Rheum Dis 2011, 70:1884-1886.
27. Altman R.D., Gold G.E. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthr Cartil 2007, 15(Suppl A):1-56.
28. Neogi T., Felson D., Niu J., Nevitt M., Lewis C.E., Aliabadi P., et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 2009, 339:b2844. 10.1136/bmj.b2844.
29. Guermazi A., Roemer F.W., Felson D.T., Brandt K.D. Motion for debate: osteoarthritis clinical trials have not identified efficacious therapies because traditional imaging outcome measures are inadequate. Arthritis Rheum 2013, 65:2748-2758.
30. Duryea J., Neumann G., Niu J., Totterman S., Tamez J., Dabrowski C., et al. Comparison of radiographic joint space width with magnetic resonance imaging cartilage morphometry: analysis of longitudinal data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2010, 62:932-937.
31. Wirth W., Duryea J., Hellio Le Graverand M.P., John M.R., Nevitt M., Buck R.J., et al. Direct comparison of fixed flexion, radiography and MRI in knee osteoarthritis: responsiveness data from the Osteoarthritis Initiative. Osteoarthr Cartil 2013, 21:117-125.
32. Ornetti P., Brandt K., Hellio-Le Graverand M.P., Hochberg M., Hunter D.J., Kloppenburg M., et al. OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. Osteoarthr Cartil 2009, 17:856-863.
33. Bruyere O., Richy F., Reginster J.Y. Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up study. Ann Rheum Dis 2005, 64:1727-1730.
34. Bruyere O., Pavelka K., Rovati L.C., Gatterova J., Giacovelli G., Olejarova M., et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthr Cartil 2008, 16:254-260.
35. Oak S.R., Ghodadra A., Winalski C.S., Miniaci A., Jones M.H. Radiographic joint space width is correlated with 4-year clinical outcomes in patients with knee osteoarthritis: data from the osteoarthritis initiative. Osteoarthr Cartil 2013, 21:1185-1190.
36. Belo J.N., Berger M.Y., Reijman M., Koes B.W., Bierma-Zeinstra S.M. Prognostic factors of progression of osteoarthritis of the knee: a systematic review of observational studies. Arthritis Rheum 2007, 57:13-26.
37. Zhang Y., Niu J., Felson D.T., Choi H.K., Nevitt M., Neogi T. Methodologic challenges in studying risk factors for progression of knee osteoarthritis. Arthritis Care Res (Hoboken) 2010, 62:1527-1532.
38. Sharma L., Song J., Felson D.T., Cahue S., Shamiyeh E., Dunlop D.D. The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA 2001, 286:188-195.
39. Felson D.T., Niu J., Gross K.D., Englund M., Sharma L., Cooke T.D., et al. Valgus malalignment is a risk factor for lateral knee osteoarthritis incidence and progression: findings from the Multicenter Osteoarthritis Study and the Osteoarthritis Initiative. Arthritis Rheum 2013, 65:355-362.
40. Felson D.T., Goggins J., Niu J., Zhang Y., Hunter D.J. The effect of body weight on progression of knee osteoarthritis is dependent on alignment. Arthritis Rheum 2004, 50:3904-3909.
41. Cerejo R., Dunlop D.D., Cahue S., Channin D., Song J., Sharma L. The influence of alignment on risk of knee osteoarthritis progression according to baseline stage of disease. Arthritis Rheum 2002, 46:2632-2636.
42. Felson D., Niu J., Sack B., Aliabadi P., McCullough C., Nevitt M.C. Progression of osteoarthritis as a state of inertia. Ann Rheum Dis 2013, 72:924-929.
43. Jubb R.W., Piva S., Beinat L., Dacre J., Gishen P. Aone-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. Int J Clin Pract 2003, 57:467-474.
44. Spector T.D., Conaghan P.G., Buckland-Wright J.C., Garnero P., Cline G.A., Beary J.F., et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther 2005, 7:R625-R633.
45. Bingham C.O., Buckland-Wright J.C., Garnero P., Cohen S.B., Dougados M., Adami S., et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006, 54:3494-3507.
46. Brandt K.D., Mazzuca S.A., Katz B.P., Lane K.A., Buckwalter K.A., Yocum D.E., et al. Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum 2005, 52:2015-2025.
47. Reginster J.Y., Badurski J., Bellamy N., Bensen W., Chapurlat R., Chevalier X., et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis 2013, 72:179-186.
48. Mazzuca S.A., Brandt K.D., Chakr R., Lane K.A. Varus malalignment negates the structure-modifying benefits of doxycycline in obese women with knee osteoarthritis. Osteoarthr Cartil 2010, 18:1008-1011.
49. Cooke T.D., Sled E.A., Scudamore R.A. Frontal plane knee alignment: a call for standardized measurement. JRheumatol 2007, 34:1796-1801.
50. Kraus V.B., Vail T.P., Worrell T., McDaniel G. Acomparative assessment of alignment angle of the knee by radiographic and physical examination methods. Arthritis Rheum 2005, 52:1730-1735.
51. Felson D.T., Cooke T.D., Niu J., Goggins J., Choi J., Yu J., et al. Can anatomic alignment measured from a knee radiograph substitute for mechanical alignment from full limb films?. Osteoarthr Cartil 2009, 17:1448-1452.
52. Buckland-Wright J.C., Messent E.A., Bingham C.O., Ward R.J., Tonkin C. A2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology (Oxford) 2007, 46:257-264.
53. Kraus V.B., Feng S., Wang S., White S., Ainslie M., Graverand M.P., et al. Subchondral bone trabecular integrity predicts and changes concurrently with radiographic and magnetic resonance imaging-determined knee osteoarthritis progression. Arthritis Rheum 2013, 65:1812-1821.
54. Peterfy C.G., Guermazi A., Zaim S., Tirman P.F., Miaux Y., White D., et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthr Cartil 2004, 12:177-190.
55. Roemer F.W., Guermazi A., Lynch J.A., Peterfy C.G., Nevitt M.C., Webb N., et al. Short tau inversion recovery and proton density-weighted fat suppressed sequences for the evaluation of osteoarthritis of the knee with a 1.0T dedicated extremity MRI: development of a time-efficient sequence protocol. Eur Radiol 2005, 15:978-987.
56. Kijowski R., Blankenbaker D.G., Davis K.W., Shinki K., Kaplan L.D., De Smet A.A. Comparison of 1.5- and 3.0-T MR imaging for evaluating the articular cartilage of the knee joint. Radiology 2009, 250:839-848.
57. Roemer F.W., Kwoh C.K., Hannon M.J., Crema M.D., Moore C.E., Jakicic J.M., et al. Semiquantitative assessment of focal cartilage damage at 3T MRI: a comparative study of dual echo at steady state (DESS) and intermediate-weighted (IW) fat suppressed fast spin echo sequences. Eur J Radiol 2011, 80:e126-e131.
58. Hayashi D., Guermazi A., Kwoh C.K., Hannon M.J., Moore C., Jakicic J.M., et al. Semiquantitative assessment of subchondral bone marrow edema-like lesions and subchondral cysts of the knee at 3T MRI: a comparison between intermediate-weighted fat-suppressed spin echo and dual echo steady state sequences. BMC Musculoskelet Disord 2011, 12:198.
59. Hunter D.J., Guermazi A., Lo G.H., Grainger A.J., Conaghan P.G., Boudreau R.M., et al. Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score). Osteoarthr Cartil 2011, 19:990-1002.
60. Graichen H., Eisenhart-Rothe R., Vogl T., Englmeier K.H., Eckstein F. Quantitative assessment of cartilage status in osteoarthritis by quantitative magnetic resonance imaging: technical validation for use in analysis of cartilage volume and further morphologic parameters. Arthritis Rheum 2004, 50:811-816.
61. Eckstein F., Buck R.J., Burstein D., Charles H.C., Crim J., Hudelmaier M., et al. Precision of 3.0 Tesla quantitative magnetic resonance imaging of cartilage morphology in a multicentre clinical trial. Ann Rheum Dis 2008, 67:1683-1688.
62. Eckstein F., Charles H.C., Buck R.J., Kraus V.B., Remmers A.E., Hudelmaier M., et al. Accuracy and precision of quantitative assessment of cartilage morphology by magnetic resonance imaging at 3.0T. Arthritis Rheum 2005, 52:3132-3136.
63. Balamoody S., Williams T.G., Waterton J.C., Bowes M., Hodgson R., Taylor C.J., et al. Comparison of 3T MR scanners in regional cartilage-thickness analysis in osteoarthritis: a cross-sectional multicenter, multivendor study. Arthritis Res Ther 2010, 12:R202.
64. Hudelmaier M., Glaser C., Pfau C., Eckstein F. Comparison between different implementations of the 3D FLASH sequence for knee cartilage quantification. MAGMA 2012, 25:305-312.
65. Schneider E., Nevitt M., McCulloch C., Cicuttini F.M., Duryea J., Eckstein F., et al. Equivalence and precision of knee cartilage morphometry between different segmentation teams, cartilage regions, and MR acquisitions. Osteoarthr Cartil 2012, 20:869-879.
66. Wirth W., Nevitt M., Hellio Le Graverand M.P., Benichou O., Dreher D., Davies R.Y., et al. Sensitivity to change of cartilage morphometry using coronal FLASH, sagittal DESS, and coronal MPR DESS protocols-comparative data from the Osteoarthritis Initiative (OAI). Osteoarthr Cartil 2010, 18:547-554.
67. Eckstein F., Wyman B.T., Buck R.J., Wirth W., Maschek S., Hudelmaier M., et al. Longitudinal quantitative MR imaging of cartilage morphology in the presence of gadopentetate dimeglumine (Gd-DTPA). Magn Reson Med 2009, 61:975-980.
68. Hunter D.J., Lo G.H., Gale D., Grainger A.J., Guermazi A., Conaghan P.G. The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston Leeds Osteoarthritis Knee Score). Ann Rheum Dis 2008, 67:206-211.
69. Lynch J.A., Roemer F.W., Nevitt M.C., Felson D.T., Niu J., Eaton C.B., et al. Comparison of BLOKS and WORMS scoring systems part I. Cross sectional comparison of methods to assess cartilage morphology, meniscal damage and bone marrow lesions on knee MRI: data from the osteoarthritis initiative. Osteoarthr Cartil 2010, 18:1393-1401.
70. Felson D.T., Lynch J., Guermazi A., Roemer F.W., Niu J., McAlindon T., et al. Comparison of BLOKS and WORMS scoring systems part II. Longitudinal assessment of knee MRIs for osteoarthritis and suggested approach based on their performance: data from the Osteoarthritis Initiative. Osteoarthr Cartil 2010, 18:1402-1407.
71. Eckstein F., Wirth W., Nevitt M.C. Recent advances in osteoarthritis imaging-the Osteoarthritis Initiative. Nat Rev Rheumatol 2012, 8:622-630.
72. Katz J.N., Brophy R.H., Chaisson C.E., de C.L., Cole B.J., Dahm D.L., et al. Surgery versus physical therapy for a meniscal tear and osteoarthritis. NEngl J Med 2013, 368:1675-1684.
73. Roemer F.W., Nevitt M.C., Felson D.T., Niu J., Lynch J.A., Crema M.D., et al. Predictive validity of within-grade scoring of longitudinal changes of MRI-based cartilage morphology and bone marrow lesion assessment in the tibio-femoral joint-the MOST study. Osteoarthr Cartil 2012, 20:1391-1398.
74. Hunter D.J., Zhang W., Conaghan P.G., Hirko K., Menashe L., Reichmann W.M., et al. Responsiveness and reliability of MRI in knee osteoarthritis: a meta-analysis of published evidence. Osteoarthr Cartil 2011, 19:589-605.
75. Hunter D.J., Zhang W., Conaghan P.G., Hirko K., Menashe L., Li L., et al. Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. Osteoarthr Cartil 2011, 19:557-588.
76. Wildi L.M., Raynauld J.P., Martel-Pelletier J., Abram F., Dorais M., Pelletier J.P. Relationship between bone marrow lesions, cartilage loss and pain in knee osteoarthritis: results from a randomised controlled clinical trial using MRI. Ann Rheum Dis 2010, 69:2118-2124.
77. Wildi L.M., Raynauld J.P., Martel-Pelletier J., Beaulieu A., Bessette L., Morin F., et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis 2011, 70:982-989.
78. Wang Y., Hall S., Hanna F., Wluka A.E., Grant G., Marks P., et al. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord 2011, 12:195.
79. Pelletier J.P., Roubille C., Raynauld J.P., Abram F., Dorais M., Delorme P., et al. Disease-modifying effect of strontium ranelate in a subset of patients from the Phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone marrow lesions protects against cartilage loss. Ann Rheum Dis 2013 Dec 2, [Epub ahead of print].
80. Eckstein F., Ateshian G., Burgkart R., Burstein D., Cicuttini F., Dardzinski B., et al. Proposal for a nomenclature for magnetic resonance imaging based measures of articular cartilage in osteoarthritis. Osteoarthr Cartil 2006, 14:974-983.
81. Raynauld J.P., Martel-Pelletier J., Abram F., Dorais M., Haraoui B., Choquette D., et al. Analysis of the precision and sensitivity to change of different approaches to assess cartilage loss by quantitative MRI in a longitudinal multicentre clinical trial in patients with knee osteoarthritis. Arthritis Res Ther 2008, 10:R129.
82. Hudelmaier M., Wirth W., Wehr B., Kraus V., Wyman B.T., Hellio Le Graverand M.P., et al. Femorotibial cartilage morphology: reproducibility of different metrics and femoral regions, and sensitivity to change in disease. Cells Tissues Organs 2010, 192:340-350.
83. Buck R.J., Wyman B.T., Le Graverand M.P., Wirth W., Eckstein F. An efficient subset of morphological measures for articular cartilage in the healthy and diseased human knee. Magn Reson Med 2010, 63:680-690.
84. Wirth W., Eckstein F. Atechnique for regional analysis of femorotibial cartilage thickness based on quantitative magnetic resonance imaging. IEEE Trans Med Imaging 2008, 27:737-744.
85. Sharma L., Eckstein F., Song J., Guermazi A., Prasad P., Kapoor D., et al. Relationship of meniscal damage, meniscal extrusion, malalignment, and joint laxity to subsequent cartilage loss in osteoarthritic knees. Arthritis Rheum 2008, 58:1716-1726.
86. Buck R.J., Wyman B.T., Le Graverand M.P., Hudelmaier M., Wirth W., Eckstein F. Osteoarthritis may not be a one-way-road of cartilage loss - comparison of spatial patterns of cartilage change between osteoarthritic and healthy knees. Osteoarthr Cartil 2010, 18:329-335.
87. Cotofana S., Wyman B.T., Benichou O., Dreher D., Nevitt M., Gardiner J., et al. Relationship between knee pain and the presence, location, size and phenotype of femorotibial denuded areas of subchondral bone as visualized by MRI. Osteoarthr Cartil 2013, 21:1214-1222.
88. Moisio K., Eckstein F., Chmiel J.S., Guermazi A., Prasad P., Almagor O., et al. Denuded subchondral bone and knee pain in persons with knee osteoarthritis. Arthritis Rheum 2009, 60:3703-3710.
89. Cicuttini F.M., Jones G., Forbes A., Wluka A.E. Rate of cartilage loss at two years predicts subsequent total knee arthroplasty: a prospective study. Ann Rheum Dis 2004, 63:1124-1127.
90. Raynauld J.P., Martel-Pelletier J., Haraoui B., Choquette D., Dorais M., Wildi L.M., et al. Risk factors predictive of joint replacement in a 2-year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation. Ann Rheum Dis 2011, 70:1382-1388.
91. Eckstein F., Kwoh C.K., Boudreau R., Wang Z., Hannon M., Cotofana S., et al. Quantitative magnetic resonance imaging measures of cartilage predict knee replacement - a case-control study from the Osteoarthritis Initiative. Ann Rheum Dis 2013, 707-714.
92. Cicuttini F.M., Wluka A.E., Wang Y., Stuckey S.L. Longitudinal study of changes in tibial and femoral cartilage in knee osteoarthritis. Arthritis Rheum 2004, 50:94-97.
93. Raynauld J.P., Martel-Pelletier J., Berthiaume M.J., Labonte F., Beaudoin G., de Guise J.A., et al. Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes. Arthritis Rheum 2004, 50:476-487.
94. Wluka A.E., Forbes A., Wang Y., Hanna F., Jones G., Cicuttini F.M. Knee cartilage loss in symptomatic knee osteoarthritis over 4.5 years. Arthritis Res Ther 2006, 8:R90.
95. Raynauld J.P., Martel-Pelletier J., Berthiaume M.J., Beaudoin G., Choquette D., Haraoui B., et al. Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes. Arthritis Res Ther 2006, 8:R21.
96. Eckstein F., Wirth W., Hudelmaier M., Stein V., Lengfelder V., Cahue S., et al. Patterns of femorotibial cartilage loss in knees with neutral, varus, and valgus alignment. Arthritis Rheum 2008, 59:1563-1570.
97. Pelletier J.P., Raynauld J.P., Berthiaume M.J., Abram F., Choquette D., Haraoui B., et al. Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study. Arthritis Res Ther 2007, 9:R74.
98. Eckstein F., Le Graverand M.P., Charles H.C., Hunter D.J., Kraus V.B., Sunyer T., et al. Clinical, radiographic, molecular and MRI-based predictors of cartilage loss in knee osteoarthritis. Ann Rheum Dis 2011, 70:1223-1230.
99. Eckstein F., Nevitt M., Gimona A., Picha K., Lee J.H., Davies R.Y., et al. Rates of change and sensitivity to change in cartilage morphology in healthy knees and in knees with mild, moderate, and end-stage radiographic osteoarthritis: results from 831 participants from the osteoarthritis initiative. Arthritis Care Res (Hoboken) 2011, 63:311-319.
100. Saunders J., Ding C., Cicuttini F., Jones G. Radiographic osteoarthritis and pain are independent predictors of knee cartilage loss: a prospective study. Intern Med J 2012, 42:274-280.
101. Wirth W., Nevitt M., Le Graverand M.P., Lynch J., Maschek S., Hudelmaier M., et al. Lateral and medial joint space narrowing predict subsequent cartilage loss in the narrowed, but not in the non-narrowed femorotibial compartment - data from the osteoarthritis initiative. Osteoarthr Cartil 2014, 22:63-70.
102. Eckstein F., Cotofana S., Wirth W., Nevitt M., John M.R., Dreher D., et al. Greater rates of cartilage loss in painful knees than in pain-free knees after adjustment for radiographic disease stage: data from the osteoarthritis initiative. Arthritis Rheum 2011, 63:2257-2267.
103. Bruyere O., Collette J., Kothari M., Zaim S., White D., Genant H., et al. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 2006, 65:1050-1054.
104. Berthiaume M.J., Raynauld J.P., Martel-Pelletier J., Labonte F., Beaudoin G., Bloch D.A., et al. Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging. Ann Rheum Dis 2005, 64:556-563.
105. Wirth W., Buck R., Nevitt M., Le Graverand M.P., Benichou O., Dreher D., et al. MRI-based extended ordered values more efficiently differentiate cartilage loss in knees with and without joint space narrowing than region-specific approaches using MRI or radiography-data from the OA initiative. Osteoarthr Cartil 2011, 19:689-699.
106. Ding C., Cicuttini F., Jones G. Do NSAIDs affect longitudinal changes in knee cartilage volume and knee cartilage defects in older adults?. Am J Med 2009, 122:836-842.
107. Martel-Pelletier J., Roubille C., Abram F., Hochberg M.C., Dorais M., Delorme P., et al. First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort. Ann Rheum Dis 2013 Dec 13, [Epub ahead of print].
108. Laslett L.L., Kingsbury S.R., Hensor E.M., Bowes M.A., Conaghan P.G. Effect of bisphosphonate use in patients with symptomatic and radiographic knee osteoarthritis: data from the Osteoarthritis Initiative. Ann Rheum Dis 2014, 73:824-830.
109. Cotofana S., Ring-Dimitriou S., Hudelmaier M., Himmer M., Wirth W., Sanger A.M., et al. Effects of exercise intervention on knee morphology in middle-aged women: a longitudinal analysis using magnetic resonance imaging. Cells Tissues Organs 2010, 192:64-72.
110. Intema F., Van Roermund P.M., Marijnissen A.C., Cotofana S., Eckstein F., Castelein R.M., et al. Tissue structure modification in knee osteoarthritis by use of joint distraction: an open 1-year pilot study. Ann Rheum Dis 2011, 70:1441-1446.
111. Raynauld J.P., Martel-Pelletier J., Beaulieu A., Bessette L., Morin F., Choquette D., et al. An open-label pilot study evaluating by magnetic resonance imaging the potential for a disease-modifying effect of celecoxib compared to a modelized historical control cohort in the treatment of knee osteoarthritis. Semin Arthritis Rheum 2010, 40:185-192.
112. Raynauld J.P., Martel-Pelletier J., Bias P., Laufer S., Haraoui B., Choquette D., et al. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis 2009, 68:938-947.
113. McAlindon T., LaValley M., Schneider E., Nuite M., Lee J.Y., Price L.L., et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 2013, 309:155-162.
114. Lohmander L.S., Hellot S., Dreher D., Krantz E.F., Kruger D.S., Guermazi A., et al. Intra-articular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol 2014, 66:1820-1831.
115. Wildi L.M., Martel-Pelletier J., Abram F., Moser T., Raynauld J.P., Pelletier J.P. Assessment of cartilage changes over time in knee osteoarthritis disease-modifying osteoarthritis drug trials using semiquantitative and quantitative methods: pros and cons. Arthritis Care Res (Hoboken) 2013, 65:686-694.
116. Lammentausta E., Kiviranta P., Nissi M.J., Laasanen M.S., Kiviranta I., Nieminen M.T., et al. T2 relaxation time and delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) of human patellar cartilage at 1.5T and 9.4T: Relationships with tissue mechanical properties. JOrthop Res 2006, 24:366-374.
117. Maier C.F., Tan S.G., Hariharan H., Potter H.G. T2 quantitation of articular cartilage at 1.5T. JMagn Reson Imaging 2003, 17:358-364.
118. Staroswiecki E., Granlund K.L., Alley M.T., Gold G.E., Hargreaves B.A. Simultaneous estimation of T(2) and apparent diffusion coefficient in human articular cartilage invivo with a modified three-dimensional double echo steady state (DESS) sequence at 3T. Magn Reson Med 2012, 67:1086-1096.
119. Heule R., Ganter C., Bieri O. Rapid estimation of cartilage T with reduced T sensitivity using double echo steady state imaging. Magn Reson Med 2013 May 10, [Epub ahead of print].
120. Mosher T.J., Zhang Z., Reddy R., Boudhar S., Milestone B.N., Morrison W.B., et al. Knee articular cartilage damage in osteoarthritis: analysis of MR image biomarker reproducibility in ACRIN-PA 4001 multicenter trial. Radiology 2011, 58:822-842.
121. Jungmann P.M., Kraus M.S., Nardo L., Liebl H., Alizai H., Joseph G.B., et al. T2 relaxation time measurements are limited in monitoring progression, once advanced cartilage defects at the knee occur: longitudinal data from the osteoarthritis initiative. JMagn Reson Imaging 2013, 38:1415-1424.
122. Schooler J., Kumar D., Nardo L., McCulloch C., Li X., Link T.M., et al. Longitudinal evaluation of T1rho and T2 spatial distribution in osteoarthritic and healthy medial knee cartilage. Osteoarthr Cartil 2014, 22:51-62.
123. Menezes N.M., Gray M.L., Hartke J.R., Burstein D. T2 and T1rho MRI in articular cartilage systems. Magn Reson Med 2004, 51:503-509.
124. Burstein D., Gray M., Mosher T., Dardzinski B. Measures of molecular composition and structure in osteoarthritis. Radiol Clin North Am 2009, 47:675-686.
125. van Tiel J., Bron E.E., Tiderius C.J., Bos P.K., Reijman M., Klein S., et al. Reproducibility of 3D delayed gadolinium enhanced MRI of cartilage (dGEMRIC) of the knee at 3.0T in patients with early stage osteoarthritis. Eur Radiol 2013, 23:496-504.
126. Crema M.D., Hunter D.J., Burstein D., Roemer F.W., Li L., Eckstein F., et al. Association of changes in delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) with changes in cartilage thickness in the medial tibiofemoral compartment of the knee: a 2 year follow-up study using 3.0T MRI. Ann Rheum Dis 2013 Jul 19, [Epub ahead of print].
127. Stewart R.C., Bansal P.N., Entezari V., Lusic H., Nazarian R.M., Snyder B.D., et al. Contrast-enhanced CT with a high-affinity cationic contrast agent for imaging exvivo bovine, intact exvivo rabbit, and invivo rabbit cartilage. Radiology 2013, 266:141-150.
128. Newbould R.D., Miller S.R., Upadhyay N., Rao A.W., Swann P., Gold G.E., et al. T1-weighted sodium MRI of the articulator cartilage in osteoarthritis: a cross sectional and longitudinal study. PLoS One 2013, 8:e73067.
129. Ling W., Regatte R.R., Navon G., Jerschow A. Assessment of glycosaminoglycan concentration invivo by chemical exchange-dependent saturation transfer (gagCEST). Proc Natl Acad Sci U S A 2008, 105:2266-2270.
130. Singh A., Haris M., Cai K., Kassey V.B., Kogan F., Reddy D., et al. Chemical exchange saturation transfer magnetic resonance imaging of human knee cartilage at 3T and 7T. Magn Reson Med 2012, 68:588-594.
131. Du J., Carl M., Bae W.C., Statum S., Chang E.Y., Bydder G.M., et al. Dual inversion recovery ultrashort echo time (DIR-UTE) imaging and quantification of the zone of calcified cartilage (ZCC). Osteoarthr Cartil 2013, 21:77-85.
132. Anandacoomarasamy A., Leibman S., Smith G., Caterson I., Giuffre B., Fransen M., et al. Weight loss in obese people has structure-modifying effects on medial but not on lateral knee articular cartilage. Ann Rheum Dis 2012, 71:26-32.
133. McAlindon T.E., Nuite M., Krishnan N., Ruthazer R., Price L.L., Burstein D., et al. Change in knee osteoarthritis cartilage detected by delayed gadolinium enhanced magnetic resonance imaging following treatment with collagen hydrolysate: a pilot randomized controlled trial. Osteoarthr Cartil 2011, 19:399-405.
134. Driban J.B., Tassinari A., Lo G.H., Price L.L., Schneider E., Lynch J.A., et al. Bone marrow lesions are associated with altered trabecular morphometry. Osteoarthr Cartil 2012, 20:1519-1526.
135. Pang J., Driban J.B., Destenaves G., Miller E., Lo G.H., Ward R.J., et al. Quantification of bone marrow lesion volume and volume change using semi-automated segmentation: data from the osteoarthritis initiative. BMC Musculoskelet Disord 2013, 14:3.
136. Driban J.B., Price L.L., Lo G.H., Pang J., Hunter D.J., Miller E., et al. Evaluation of bone marrow lesion volume as a knee osteoarthritis biomarker - longitudinal relationships with pain and structural changes: data from the Osteoarthritis Initiative. Arthritis Res Ther 2013, 15:R112.
137. Bredbenner T.L., Eliason T.D., Potter R.S., Mason R.L., Havill L.M., Nicolella D.P. Statistical shape modeling describes variation in tibia and femur surface geometry between Control and Incidence groups from the osteoarthritis initiative database. JBiomech 2010, 43:1780-1786.
138. Ababneh S.Y., Prescott J.W., Gurcan M.N. Automatic graph-cut based segmentation of bones from knee magnetic resonance images for osteoarthritis research. Med Image Anal 2011, 15:438-448.
139. Bowes M.A., Vincent G.R., Wolstenholme C.B., Conaghan P.G. Anovel method for bone area measurement provides new insights into osteoarthritis and its progression. Ann Rheum Dis 2013 Dec 4, [Epub ahead of print].
140. Neogi T., Bowes M.A., Niu J., De Souza K.M., Vincent G.R., Goggins J., et al. Magnetic resonance imaging-based three-dimensional bone shape of the knee predicts onset of knee osteoarthritis: data from the osteoarthritis initiative. Arthritis Rheum 2013, 65:2048-2058.
141. Bolbos R.I., Zuo J., Banerjee S., Link T.M., Ma C.B., Li X., et al. Relationship between trabecular bone structure and articular cartilage morphology and relaxation times in early OA of the knee joint using parallel MRI at 3T. Osteoarthr Cartil 2008, 16:1150-1159.
142. Lo G.H., Tassinari A.M., Driban J.B., Price L.L., Schneider E., Majumdar S., et al. Cross-sectional DXA and MR measures of tibial periarticular bone associate with radiographic knee osteoarthritis severity. Osteoarthr Cartil 2012, 20:686-693.
143. Driban J.B., Lo G.H., Price L., Pang J., Miller E., Ward R.J., et al. Bone marrow lesion volume reduction is not associated with improvement of other periarticular bone measures: data from the Osteoarthritis Initiative. Arthritis Res Ther 2013, 15:R153.
144. Reginster J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001, 357:251-256.
145. Lowitz T., Museyko O., Bousson V., Laouisset L., Kalender W.A., Laredo J.D., et al. Bone marrow lesions identified by MRI in knee osteoarthritis are associated with locally increased bone mineral density measured by QCT. Osteoarthr Cartil 2013, 21:957-964.
146. Bousson V., Lowitz T., Laouisset L., Engelke K., Laredo J.D. CT imaging for the investigation of subchondral bone in knee osteoarthritis. Osteoporos Int 2012, 23(Suppl 8):S861-S865.
147. Cromer M.S., Bourne R.M., Fransen M., Fulton R., Wang S.C. Responsiveness of quantitative cartilage measures over one year in knee osteoarthritis: comparison of radiography and MRI assessments. JMagn Reson Imaging 2014, 39:103-109.
148. Le Graverand M.P., Buck R.J., Wyman B.T., Vignon E., Mazzuca S.A., Brandt K.D., et al. Change in regional cartilage morphology and joint space width in osteoarthritis participants versus healthy controls: a multicentre study using 3.0 Tesla MRI and Lyon-Schuss radiography. Ann Rheum Dis 2010, 69:155-162.
149. Cicuttini F., Hankin J., Jones G., Wluka A. Comparison of conventional standing knee radiographs and magnetic resonance imaging in assessing progression of tibiofemoral joint osteoarthritis. Osteoarthr Cartil 2005, 13:722-727.
150. Bruyere O., Genant H., Kothari M., Zaim S., White D., Peterfy C., et al. Longitudinal study of magnetic resonance imaging and standard X-rays to assess disease progression in osteoarthritis. Osteoarthr Cartil 2007, 15:98-103.